281 related articles for article (PubMed ID: 22450705)
1. Structural features and cytotoxicity of amyloid oligomers: implications in Alzheimer's disease and other diseases with amyloid deposits.
Stefani M
Prog Neurobiol; 2012 Dec; 99(3):226-45. PubMed ID: 22450705
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and biophysical features of both oligomer/fibril and cell membrane in amyloid cytotoxicity.
Stefani M
FEBS J; 2010 Nov; 277(22):4602-13. PubMed ID: 20977664
[TBL] [Abstract][Full Text] [Related]
3. The amyloid-cell membrane system. The interplay between the biophysical features of oligomers/fibrils and cell membrane defines amyloid toxicity.
Cecchi C; Stefani M
Biophys Chem; 2013 Dec; 182():30-43. PubMed ID: 23820236
[TBL] [Abstract][Full Text] [Related]
4. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
Meredith SC
Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
[TBL] [Abstract][Full Text] [Related]
5. Protein aggregation diseases: toxicity of soluble prefibrillar aggregates and their clinical significance.
Stefani M
Methods Mol Biol; 2010; 648():25-41. PubMed ID: 20700703
[TBL] [Abstract][Full Text] [Related]
6. Atomic force microscopy to study molecular mechanisms of amyloid fibril formation and toxicity in Alzheimer's disease.
Drolle E; Hane F; Lee B; Leonenko Z
Drug Metab Rev; 2014 May; 46(2):207-23. PubMed ID: 24495298
[TBL] [Abstract][Full Text] [Related]
7. Structural polymorphism of amyloid oligomers and fibrils underlies different fibrillization pathways: immunogenicity and cytotoxicity.
Stefani M
Curr Protein Pept Sci; 2010 Aug; 11(5):343-54. PubMed ID: 20423295
[TBL] [Abstract][Full Text] [Related]
8. Structure and intermolecular dynamics of aggregates populated during amyloid fibril formation studied by hydrogen/deuterium exchange.
Carulla N; Zhou M; Giralt E; Robinson CV; Dobson CM
Acc Chem Res; 2010 Aug; 43(8):1072-9. PubMed ID: 20557067
[TBL] [Abstract][Full Text] [Related]
9. Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases.
Ferreira ST; Vieira MN; De Felice FG
IUBMB Life; 2007; 59(4-5):332-45. PubMed ID: 17505973
[TBL] [Abstract][Full Text] [Related]
10. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.
Rijal Upadhaya A; Capetillo-Zarate E; Kosterin I; Abramowski D; Kumar S; Yamaguchi H; Walter J; Fändrich M; Staufenbiel M; Thal DR
Neurobiol Aging; 2012 Nov; 33(11):2641-60. PubMed ID: 22305478
[TBL] [Abstract][Full Text] [Related]
11. Fibrillar seeds alleviate amyloid-β cytotoxicity by omitting formation of higher-molecular-weight oligomers.
Wu WH; Liu Q; Sun X; Yu JS; Zhao DS; Yu YP; Luo JJ; Hu J; Yu ZW; Zhao YF; Li YM
Biochem Biophys Res Commun; 2013 Sep; 439(3):321-6. PubMed ID: 24012671
[TBL] [Abstract][Full Text] [Related]
12. Oligomeric intermediates in amyloid formation: structure determination and mechanisms of toxicity.
Fändrich M
J Mol Biol; 2012 Aug; 421(4-5):427-40. PubMed ID: 22248587
[TBL] [Abstract][Full Text] [Related]
13. Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization.
De Felice FG; Vieira MN; Saraiva LM; Figueroa-Villar JD; Garcia-Abreu J; Liu R; Chang L; Klein WL; Ferreira ST
FASEB J; 2004 Sep; 18(12):1366-72. PubMed ID: 15333579
[TBL] [Abstract][Full Text] [Related]
14. Toxic effects of amyloid fibrils on cell membranes: the importance of ganglioside GM1.
Bucciantini M; Nosi D; Forzan M; Russo E; Calamai M; Pieri L; Formigli L; Quercioli F; Soria S; Pavone F; Savistchenko J; Melki R; Stefani M
FASEB J; 2012 Feb; 26(2):818-31. PubMed ID: 22071505
[TBL] [Abstract][Full Text] [Related]
15. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers.
Kayed R; Head E; Sarsoza F; Saing T; Cotman CW; Necula M; Margol L; Wu J; Breydo L; Thompson JL; Rasool S; Gurlo T; Butler P; Glabe CG
Mol Neurodegener; 2007 Sep; 2():18. PubMed ID: 17897471
[TBL] [Abstract][Full Text] [Related]
16. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
Tomiyama T
Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
[TBL] [Abstract][Full Text] [Related]
17. Interpreting the aggregation kinetics of amyloid peptides.
Pellarin R; Caflisch A
J Mol Biol; 2006 Jul; 360(4):882-92. PubMed ID: 16797587
[TBL] [Abstract][Full Text] [Related]
18. Conformation-dependent scFv antibodies specifically recognize the oligomers assembled from various amyloids and show colocalization of amyloid fibrils with oligomers in patients with amyloidoses.
Zhang X; Sun XX; Xue D; Liu DG; Hu XY; Zhao M; Yang SG; Yang Y; Xia YJ; Wang Y; Liu RT
Biochim Biophys Acta; 2011 Dec; 1814(12):1703-12. PubMed ID: 21979582
[TBL] [Abstract][Full Text] [Related]
19. Protein amyloidose misfolding: mechanisms, detection, and pathological implications.
Jeyashekar NS; Sadana A; Vo-Dinh T
Methods Mol Biol; 2005; 300():417-35. PubMed ID: 15657495
[TBL] [Abstract][Full Text] [Related]
20. Α-mangostin, a polyphenolic xanthone derivative from mangosteen, attenuates β-amyloid oligomers-induced neurotoxicity by inhibiting amyloid aggregation.
Wang Y; Xia Z; Xu JR; Wang YX; Hou LN; Qiu Y; Chen HZ
Neuropharmacology; 2012 Feb; 62(2):871-81. PubMed ID: 21958557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
